Investing in Myomo and the Wearable Technology Revolution

The world is changing for disabled people. For all of human history, the loss of mobility in an arm, leg, or full paralysis from a spinal cord injury, meant either death or a life of severe difficulty. For many people, this is still the reality, but new advancements in wearable medical technology are starting to change that for those lucky enough to have access to these remarkable devices. Myomo, having announced its Regulation A+ IPO, is one of the first companies to bring functional restorative technologies to the medical world, leading the way into a new standard of living for people with neurological disorders and upper limb paralysis.

Myomo’s MyoPro® is a case in point. It is a powered arm brace that is custom-fabricated for a patient’s arm and hand. It contains sensors that detect faint muscle impulses. When the impulses are detected, the brace responds with corresponding motion. While the paralyzed individual would not normally have the strength or ability to perform complex tasks like carrying or grabbing, the brain will still provoke enough muscular reaction to guide the MyoPro® through the correct movements, aiding the patient through these tasks. It sounds more complicated than it is (at least from the user perspective); the MyoPro® is incredibly intuitive.

MyoPro® is the first such company to announce a Regulation A+ IPO. It’s not difficult to see how devices like these will become industry standard, offering new life to a set of patients for whom there has been little actionable progress in the area of independent mobility, at least until now.

Readers of this blog tend to always be on the lookout for the new, interesting, and revolutionary. While there are readers who will want to try the device themselves to achieve greater mobility, others will be interested in the return potential of Myomo stock. As with all IPOs, no one really knows how the value will be assessed by investors in its early days. On the other hand, it’s impossible to ignore the revolutionary nature of these products, anticipating the great demand in this industry.

It’s safe to say that lots of people are going to get rich bringing devices like these to market. We always advise our readers to do their own research, but we honestly believe that Myomo is a good place to look for value. Learn about their place in the industry and make your own judgment. Meanwhile we’ll be following (and possibly investing) with great interest.

Myomo Inc.‘s offering statement for its initial public offering under Regulation A has been qualified by the Securities and Exchange Commission. The securities offered by Myomo Inc. are highly speculative. Investing in shares of Myomo Inc. involves significant risks. The investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that such investment could be illiquid for an indefinite period of time. No public market currently exists for the securities, and if a public market develops following the offering, it may not continue. To obtain a copy of the Offering Circular, go to Myomo Form 1-A at

Modest Money is compensated by CrowdfundX on behalf of Myomo for publicizing the offering of Myomo’s securities. The total fees to be paid to Modest Money for its services are $500, payable in cash.

Photo Source